A Pilot Study to Evaluate Rebounding vs. Active Range of Motion Exercises to Reduce Upper Limb Extremity Lymphedema Related to Breast Cancer Treatments.
Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmesis in Patients with Multiple Ipsilateral Breast Cancers (MIBC)
A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-Stage Breast Cancer
RTOG 0413/NSABP B-39
A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer
A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy.
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or Less.
A Single Site Prospective, Non- randomized Study of the MammoSite® Radiation Therapy Delivery System (Breast Brachytherapy Applicator) to Evaluate Local Tumor Control, Cosmetic Outcome, and Toxicities.
Phase II Study of Lactobacillus and Bifidobacterium Supplementation (Theralac®) in Reducing the Severity and Frequency of Cancer Treatment Induced Diarrhea .
A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy
Phase III Trial of Dose Escalated Radiation Therapy and Standard Androgen Deprivation Therapy (ADT) with a GnRH Agonist vs. Dose Escalated Radiation Therapy and Enhanced ADT with a GnRH Agonist and TAK-700 for Men with High Risk Prostate Cancer
EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head and Neck Cancer.
A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients with Completely Resected Stage IB (> 4cm) – IIIA Non-Small Cell Lung Cancer (NSCLC).
Prostate Cancer Registry Study – CyberKnife® Radiosurgery versus External Beam Radiation Therapy
Dysphagia after Irradiation to Pharyngeal Constrictor Muscles Measured in Terms of Quality of Life
Functional Outcomes in Single-strand vs. Double-strand Sural Interposition Coaptation in Spinal Accessory Nerve Repair
A Study to Examine Reduced Screening Mammography Compliance for Women being Treated at the Breast Center at Saint Peter’s University Hospital
Connect™ CLLThe Chronic Lymphocytic Leukemia Disease Registry
A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma.
A Phase 1/2 Study of Suberoylanilide Hydroxamic Acid (SAHA, Vorinostat) and Local Irradiation, Followed by Maintenance SAHA in Children with Newly Diagnosed Diffuse Intrinsic Pontine Gliomas (DIPG)
Protocol for the Enrollment on the Official COG Registry. The Childhood Cancer Research Network (CCRN)
Key Adverse Events Following Childhood Cancer
Umbrella Long-Term Follow-up Protocol
Rare and Cutaneous Non-Hodgkin Lymphoma Registry
Neuroblastoma Biology Studies
Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors
Banking in Hodgkin Disease
Renal Tumors Classification, Biology and Banking Study
A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol
Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Biology Study of Transient Myeloproliferatie Disorder (TMD) in Children with Down Syndrome (DS)
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens
Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
Phase III Randomized Trial of Single vs. Tandem Myeloablative as Consolidation Therapy for High-Risk Neuroblastoma
A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial
Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNT Patients
A Randomized Phase II Trial of Bevacizumab (IND# 7921, Avastin) and Temsirolimus (IND# 61010, Torisel) in Combination with Intravenous Vinorelbine and Cyclophosphamide in Patients with Recurrent/Refractory Rhabdomyosarcoma
Risk Based Treatment for Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS)
Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) versus VAC alternating with Vincristin and Irinotecan (VI) for patients with Intermediate-risk Rhabdomyosarcoma (RMS)
A Phase II Pilot Trial of Bortezomib (PS-341, Velcade, IND# 58,443 ) in Combination with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)
Intensified Methotrexate, Nelarabine (Compound 506U78; IND# 52611) and Augmented BFM Therapy for children and Young Adults with Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (PK Portion Closed)
A Phase III Study of Risk Directed therapy for Infants with ALL: Randomization of Highest Risk Infants to Intensive chemotherapy +/- FLT3 Inhibition (CEP-701, Lestaurtinib; IND #76431; NSC#617807
Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
WILMS Tumor Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumor
Treatment for Pateints with Bilateral Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor
Treatment of Children with All Stages of Hepatoblastoma
Adult Clinical TrialsGopal Desai, M.D.
Chairman, Radiation Oncology
Telephone: (732) 745-6690
Alexander Haas, M.D.
Telephone: (732) 745-6689
Director of Ambulatory Oncology Services
Telephone (732) 745-6687
Cell: (908) 812-0464
Kathy Covert, APN-BC, MSN, AOCN
Oncology Research Nurse
Telephone: (732) 745-8600 ext. 6163
Beeper: (732) 651-3970
Christopher Buck, BS, MS, RN, OCN
Oncology Research Nurse
Telephone: (732) 745-8600 ext. 8295
Pediatric Clinical TrialsDr. Stan Calderwood,
Section Chief, Pediatric Hematology/ Oncology
Children’s Oncology Group Principle Investigator
Dr. Ionela Iacobas,
Vascular Malformation and Tumor Program Director
Children’s Oncology Group Co-Investigator
Clinical Research Associate
Children’s Oncology Group
© 2013 Saint Peter’s Healthcare System254 Easton Avenue, New Brunswick, NJ 08901